Asuragen, Inc.

Asuragen, Inc. — FDA 510(k) Submissions

Asuragen, Inc. has submitted 3 FDA 510(k) premarket notifications since 2012, of which 1 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Bcr/abl1 Monitoring Test, Inherited Nucleotide Repeat Disorder Dna Test, Tissue Rna Preservative For Collection, Storage, And Transportation . Use the specialty filter in the sidebar to narrow results.